Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
26.05
-0.93 (-3.45%)
Jun 11, 2026, 11:29 AM CST
Market Cap4.14B -34.3%
Revenue (ttm)3.35B -2.2%
Net Income337.40M -9.5%
EPS2.20 -10.5%
Shares Out 153.40M
PE Ratio12.27
Forward PEn/a
Dividend0.90 (3.36%)
Ex-Dividend DateApr 28, 2026
Volume952,700
Open26.89
Previous Close26.98
Day's Range25.99 - 27.02
52-Week Range26.04 - 43.72
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China. [Read more]

Sector Healthcare
Founded 1637
Employees 2,257
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.

Financial Statements